Articles related to ALZHEIMER'S/DEMENTIA

The reseachers acknowledge that the Delphi approach favors compounds already studied and may exclude agents identifiable only through high-throughput screening.

“Too many neurons go astray, and that’s when you get amyloid-beta production. And then it’s tau, and then it’s dead cells, then dementia — and then it’s too late.” — Jeffrey Savas, Northwestern University

“Disruption to the glymphatic system is likely to impair our ability to clear the brain of the amyloid and tau that causes Alzheimer’s disease.” — Hui Hong, University of Cambridge

Even if menopause does lead to some gray matter loss, it won’t automatically lead to future cognitive decline or dementia.

“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine

According to Karthikeyan Tangavelou, PhD, a professor in the Department of Molecular Genetics & Microbiology at the UNM School of Medicine: “If you stop tau synthesis by targeting OTULIN in neurons, you can restore a healthy brain and prevent brain aging.”